LONGEVERON INC-A (LGVN) Fundamental Analysis & Valuation
NASDAQ:LGVN • US54303L2034
Current stock price
0.98 USD
-0.13 (-11.71%)
At close:
0.97 USD
-0.01 (-1.02%)
After Hours:
This LGVN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. LGVN Profitability Analysis
1.1 Basic Checks
- LGVN had negative earnings in the past year.
- In the past year LGVN has reported a negative cash flow from operations.
- LGVN had negative earnings in each of the past 5 years.
- In the past 5 years LGVN always reported negative operating cash flow.
1.2 Ratios
- LGVN has a Return On Assets of -137.18%. This is amonst the worse of the industry: LGVN underperforms 82.53% of its industry peers.
- LGVN's Return On Equity of -214.14% is on the low side compared to the rest of the industry. LGVN is outperformed by 69.87% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -137.18% | ||
| ROE | -214.14% | ||
| ROIC | N/A |
ROA(3y)-116.31%
ROA(5y)-85.81%
ROE(3y)-177.95%
ROE(5y)-153.9%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- LGVN's Gross Margin of 74.88% is amongst the best of the industry. LGVN outperforms 83.30% of its industry peers.
- In the last couple of years the Gross Margin of LGVN has grown nicely.
- LGVN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 74.88% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.36%
GM growth 5Y20.42%
2. LGVN Health Analysis
2.1 Basic Checks
- LGVN does not have a ROIC to compare to the WACC, probably because it is not profitable.
- LGVN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- LGVN has an Altman-Z score of -12.53. This is a bad value and indicates that LGVN is not financially healthy and even has some risk of bankruptcy.
- LGVN has a Altman-Z score of -12.53. This is in the lower half of the industry: LGVN underperforms 77.74% of its industry peers.
- LGVN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -12.53 |
ROIC/WACCN/A
WACC9.03%
2.3 Liquidity
- A Current Ratio of 2.09 indicates that LGVN has no problem at all paying its short term obligations.
- LGVN's Current ratio of 2.09 is on the low side compared to the rest of the industry. LGVN is outperformed by 75.24% of its industry peers.
- LGVN has a Quick Ratio of 2.09. This indicates that LGVN is financially healthy and has no problem in meeting its short term obligations.
- With a Quick ratio value of 2.09, LGVN is not doing good in the industry: 73.13% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.09 | ||
| Quick Ratio | 2.09 |
3. LGVN Growth Analysis
3.1 Past
- LGVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.60%, which is quite impressive.
EPS 1Y (TTM)69.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.84%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-38.64%
3.2 Future
- The Earnings Per Share is expected to decrease by -14.67% on average over the next years. This is quite bad
- The Revenue is expected to grow by 243.64% on average over the next years. This is a very strong growth
EPS Next Y-4.79%
EPS Next 2Y-14.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-11.83%
Revenue Next 2Y236.46%
Revenue Next 3Y243.64%
Revenue Next 5YN/A
3.3 Evolution
4. LGVN Valuation Analysis
4.1 Price/Earnings Ratio
- LGVN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year LGVN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A cheap valuation may be justified as LGVN's earnings are expected to decrease with -14.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-14.67%
EPS Next 3YN/A
5. LGVN Dividend Analysis
5.1 Amount
- No dividends for LGVN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
LGVN Fundamentals: All Metrics, Ratios and Statistics
0.98
-0.13 (-11.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-17 2026-03-17/amc
Earnings (Next)N/A N/A
Inst Owners8.57%
Inst Owner Change-2.04%
Ins Owners8.61%
Ins Owner Change-0.79%
Market Cap28.69M
Revenue(TTM)N/A
Net Income(TTM)-21.34M
Analysts82.5
Price Target7 (614.29%)
Short Float %8.47%
Short Ratio0.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-20.86%
Min EPS beat(2)-49.94%
Max EPS beat(2)8.22%
EPS beat(4)1
Avg EPS beat(4)-16.87%
Min EPS beat(4)-49.94%
Max EPS beat(4)8.22%
EPS beat(8)3
Avg EPS beat(8)-18.04%
EPS beat(12)3
Avg EPS beat(12)-16.17%
EPS beat(16)5
Avg EPS beat(16)-11.14%
Revenue beat(2)0
Avg Revenue beat(2)-39.57%
Min Revenue beat(2)-52.82%
Max Revenue beat(2)-26.32%
Revenue beat(4)0
Avg Revenue beat(4)-31.04%
Min Revenue beat(4)-52.82%
Max Revenue beat(4)-7.27%
Revenue beat(8)2
Avg Revenue beat(8)140.83%
Revenue beat(12)2
Avg Revenue beat(12)81.18%
Revenue beat(16)5
Avg Revenue beat(16)72.18%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-8.26%
Revenue NQ rev (3m)-8.26%
Revenue NY rev (1m)-11.84%
Revenue NY rev (3m)-11.84%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 19.97 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.88 | ||
| P/tB | 3.75 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.28
EYN/A
EPS(NY)-1.34
Fwd EYN/A
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.57
OCFYN/A
SpS0.05
BVpS0.34
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -137.18% | ||
| ROE | -214.14% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 74.88% | ||
| FCFM | N/A |
ROA(3y)-116.31%
ROA(5y)-85.81%
ROE(3y)-177.95%
ROE(5y)-153.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.36%
GM growth 5Y20.42%
F-Score4
Asset Turnover0.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 54.96% | ||
| Cap/Sales | 45.51% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.09 | ||
| Quick Ratio | 2.09 | ||
| Altman-Z | -12.53 |
F-Score4
WACC9.03%
ROIC/WACCN/A
Cap/Depr(3y)90.92%
Cap/Depr(5y)89.88%
Cap/Sales(3y)69.8%
Cap/Sales(5y)62.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.84%
EPS Next Y-4.79%
EPS Next 2Y-14.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-38.64%
Revenue Next Year-11.83%
Revenue Next 2Y236.46%
Revenue Next 3Y243.64%
Revenue Next 5YN/A
EBIT growth 1Y-25.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.41%
OCF growth 3YN/A
OCF growth 5YN/A
LONGEVERON INC-A / LGVN Fundamental Analysis FAQ
What is the ChartMill fundamental rating of LONGEVERON INC-A (LGVN) stock?
ChartMill assigns a fundamental rating of 2 / 10 to LGVN.
Can you provide the valuation status for LONGEVERON INC-A?
ChartMill assigns a valuation rating of 0 / 10 to LONGEVERON INC-A (LGVN). This can be considered as Overvalued.
How profitable is LONGEVERON INC-A (LGVN) stock?
LONGEVERON INC-A (LGVN) has a profitability rating of 1 / 10.
How financially healthy is LONGEVERON INC-A?
The financial health rating of LONGEVERON INC-A (LGVN) is 5 / 10.